Although no individuals in this study were found to carry any variants in SLC25A20, the gene was incorporated into the CCD panel to enable its future application in broader diagnostic settings, ensuring its utility for patients who may present with CACT deficiency in prospective screenings. This evidence concerns the gene SLC25A20 and carnitine-acylcarnitine translocase deficiency.